Jim Ellis

Jim Ellis

Company: Nocion Therapeutics

Job title: Chief Scientific Officer


Antipruritic & Disease Modifying Activity of Novel Charged Sodium Channel Blockers in Inflammatory Skin Disease 1:30 pm

• Exploring how sensory nociceptors are increasingly implicated in the regulation of the immune response in inflammatory skin disease • Developing charged sodium channel blockers (nocions) that selectively target nociceptors • Learning how to use large pore channels that are open in response to inflammation to selectively enter into nociceptors where they block Nav1.7, 1.8…Read more

day: Day 2 PM - Track 1

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.